Yüklüyor......

Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression

BACKGROUND: This meta-analysis was to determine the association of the cumulative dose of 130/0.4 or 0.42 (hydroxyethyl starch [HES] 130/0.4*) or delta daily fluid balance (i.e., daily fluid balance in HES group over or below control group) with the heterogeneity of risk ratio (RR) for mortality in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Chin Med J (Engl)
Asıl Yazarlar: Ma, Peng-Lin, Peng, Xiao-Xia, Du, Bin, Hu, Xiao-Lan, Gong, Yi-Chun, Wang, Yu, Xi, Xiu-Ming
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Medknow Publications & Media Pvt Ltd 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4733795/
https://ncbi.nlm.nih.gov/pubmed/26315087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0366-6999.163387
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!